Beleave Inc. ("Beleave" or the "Company") (CSE: BE) (OTCQX: BLEVF) is pleased to announce that it has completed the construction and commissioning of a new state-of-the-art industrial extraction laboratory at its production facility located in Hamilton, Ontario. The laboratory design is based on recent work stemming from research collaborations with principal investigators at Ryerson University, Department of Chemistry and Biology, and which has led to the development of a proprietary and large-scale industrial method for the extraction and purification of cannabinoid compounds from plant tissue.

The Company has filed a patent application in the United States and Canada for this extraction method which involves the activation, purification and extraction of cannabinoid active ingredients (including Δ9-tetrahydrocannabinol [THC], and cannabidiol [CBD]) from cannabis using only ethanol and other food-grade components, without the use of organic solvents. This method delivers high purity and yields of cannabinoid compound using a process that is scalable and efficient, and has been approved by Health Canada to be implemented for cannabis oil production by Beleave's wholly-owned subsidiary, Beleave Kannabis Corp.  The Company projects an initial production capacity of 200,000 mL of cannabis oil per week and anticipates the ability to scale this up to 1,000,000 mL by Q3 2018.

"Following the approval by Health Canada to implement our newly developed proprietary extraction method for the production of cannabis oils, we are very excited to put this method into practice at an industrial scale," commented Beleave Chief Science Officer, Dr. Roger Ferreira. "We also look forward to making use of this method for R&D efforts by using high-purity cannabinoid compounds for the development of cannabis food and drug products."